Cadrenal Therapeutics (CVKD) Stock Chart & Stock Price History $17.60 +0.64 (+3.77%) (As of 11/1/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Cadrenal Therapeutics Stock Price Performance5 Day Performance+16.63%1 Month Performance+47.28% Receive CVKD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cadrenal Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. CVKD Stock Chart for Saturday, November, 2, 2024 CVKD Chart by TradingView Cadrenal Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/01/2024$16.96$17.60+3.77%$18.00$15.9567,424 shs$18.83 million10/31/2024$16.39$16.96+3.48%$17.03$15.1545,574 shs$18.11 million10/30/2024$15.54$16.39+5.47%$16.49$15.1840,339 shs$262.37 million10/29/2024$15.09$15.54+2.98%$15.90$14.7029,108 shs$248.76 million10/28/2024$15.79$15.09-4.43%$16.01$14.7044,862 shs$241.56 million10/25/2024$16.77$15.79-5.84%$17.18$15.1756,873 shs$252.77 million Get the Latest News and Ratings for CVKD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cadrenal Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/24/2024$14.19$16.77+18.18%$17.11$14.1083,439 shs$268.45 million10/23/2024$14.43$14.19-1.66%$14.55$13.6898,931 shs$227.15 million10/22/2024$15.24$14.43-5.31%$16.02$14.4075,454 shs$231.00 million10/21/2024$17.26$15.24-11.70%$17.95$15.00125,414 shs$243.96 million10/18/2024$16.30$17.26+5.89%$17.45$16.07105,559 shs$276.30 million10/17/2024$15.35$16.30+6.19%$16.45$15.63101,450 shs$260.93 million10/16/2024$14.50$15.35+5.86%$15.37$14.6096,924 shs$245.72 million10/15/2024$14.50$14.50$15.26$14.0253,241 shs$232.12 million10/14/2024$13.50$14.50+7.41%$15.93$13.1392,099 shs$232.12 million10/11/2024$11.27$13.50+19.78%$14.39$11.2771,326 shs$216.11 million10/10/2024$11.95$11.27-5.69%$11.99$11.1925,585 shs$180.42 million10/09/2024$12.38$11.95-3.47%$12.60$11.6828,196 shs$191.30 million10/08/2024$12.00$12.38+3.17%$12.55$12.1921,440 shs$198.18 million10/07/2024$12.00$12.00$12.05$11.7720,748 shs$192.10 million10/04/2024$11.40$12.00+5.26%$12.28$11.7936,996 shs$192.10 million10/03/2024$11.95$11.40-4.60%$12.63$11.0048,958 shs$182.49 million10/02/2024$12.89$11.95-7.29%$13.17$11.7550,918 shs$191.30 million10/01/2024$13.65$12.89-5.57%$14.43$12.2166,462 shs$206.34 million09/30/2024$14.50$13.65-5.86%$14.98$13.6542,262 shs$218.51 million09/27/2024$14.51$14.50-0.07%$15.06$14.5036,841 shs$232.12 million09/26/2024$14.00$14.51+3.64%$15.10$14.2058,984 shs$232.28 million09/25/2024$11.91$14.00+17.60%$15.37$11.9078,889 shs$224.11 million09/24/2024$10.18$11.91+16.94%$11.91$10.2127,308 shs$190.58 million09/23/2024$11.59$10.18-12.17%$11.62$10.0023,932 shs$162.96 million09/20/2024$11.21$11.59+3.39%$11.59$11.0038,089 shs$185.53 million09/19/2024$11.98$11.21-6.43%$12.28$11.0430,749 shs$179.45 million09/18/2024$12.00$11.98-0.17%$12.56$11.7441,821 shs$191.78 million09/17/2024$11.13$12.00+7.87%$12.92$10.9964,664 shs$192.10 million09/16/2024$10.21$11.13+8.96%$11.29$10.0041,671 shs$178.09 million09/13/2024$10.72$10.21-4.76%$11.99$9.3987,900 shs$10.93 million09/12/2024$8.32$10.72+28.85%$10.90$8.2255,135 shs$171.61 million09/11/2024$7.06$8.32+17.85%$8.56$7.0649,018 shs$133.19 million09/10/2024$7.38$7.06-4.34%$7.44$6.8914,237 shs$7.55 million09/09/2024$7.83$7.38-5.75%$7.93$7.3611,619 shs$7.90 millionWe recommended Nvidia in 2016, now we’re recommending this… (Ad)The AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry.09/06/2024$8.05$7.86-2.42%$8.00$7.6914,103 shs$125.74 million09/05/2024$8.11$8.05-0.74%$8.17$8.0112,340 shs$128.86 million09/04/2024$7.95$8.11+2.01%$8.28$8.0676,579 shs$129.83 million09/03/2024$7.61$7.95+4.47%$8.20$7.6735,303 shs$127.26 million09/02/2024$7.62$7.61-0.07%$7.80$7.3726,200 shs$121.82 million08/30/2024$7.39$7.70+4.19%$7.80$7.3726,216 shs$123.26 million08/29/2024$7.31$7.39+1.09%$7.72$7.1810,216 shs$118.30 million08/28/2024$7.90$7.31-7.47%$7.99$7.2128,224 shs$117.02 million08/27/2024$7.70$7.90+2.60%$8.20$7.8230,876 shs$126.46 million08/26/2024$7.36$7.70+4.62%$8.10$7.4092,008 shs$123.26 million08/23/2024$6.85$7.36+7.45%$7.70$6.8241,414 shs$117.82 million08/22/2024$7.25$6.85-5.52%$7.69$6.8152,813 shs$109.66 million08/21/2024$7.19$7.25+0.90%$7.79$6.8469,771 shs$116.06 million08/20/2024N/A$7.19$7.97$5.70213,099 shs$115.02 million Related Companies MESO Stock Chart ARQT Stock Chart APLT Stock Chart CRGX Stock Chart PAHC Stock Chart PHAT Stock Chart CGEM Stock Chart ZYME Stock Chart RAPP Stock Chart ANAB Stock Chart Receive CVKD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cadrenal Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CVKD) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredNothing can stop this gold rallyAfter what's felt like nearly a decade of disappointing gains, gold is stronger than ever and continues to hit...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cadrenal Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cadrenal Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CVKD Stock Alerts